Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Sustiva® (efavirenz) – New warning
August 31, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Sustiva (efavirenz) drug label, regarding QTc interval prolongation.
